June 8, 2010 โ New study findings prove continuing warfarin therapy during pacemaker or defibrillator implantation in patients with moderate to high thromboembolic risk is safe and cost-effective.
June 8, 2010 โ A recent study found a potential new molecular imaging agent combined with post-scan image processing technology could result in crisper pictures of the heart. The results were revealed yesterday at the Society of Nuclear Medicine (SNM) annual meeting in Salt Lake City.
June 7, 2010 โ St. Jude Medical and two hospitals agreed to pay $3.7 million to resolve allegations it paid illegal kickbacks to two hospitals to secure heart-device business, the Justice Department (DOJ) said. The government alleges the kickbacks caused false claims to be submitted to federal health care programs in violation of the False Claims Act.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 7, 2010 โ Low-dose, flat-panel computed tomography (CT) iterative reconstruction was added to the BrightView XCT single photon emission computed tomography (SPECT)/CT system. The Full Iterative Technology (FIT) feature improves localization through better uniformity and less noise, leading to improvements in soft tissue image quality.
June 7, 2010 โ A program proactively monitors molecular imaging system performance online and in real-time to help predict scanner breakdowns. The system can also detect the majority of potential computed tomography (CT) tube failures.
June 4, 2010 โ One-year mortality rates were very low for 1,038 high-risk patients, many of whom were too sick to undergo traditional open-heart surgery, who received the Sapien transcatheter heart valve. Results of the SOURCE Registry were presented last week at EuroPCR in Paris.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 4, 2010 โ Speech understanding technology that accepts data and translates additional physician dictation in real time into a structured document was introduced yesterday at the Annual Meeting of the Society of Imaging Informatics in Medicine (SIIM) in Minneapolis.
June 4, 2010 โ The first national contract signed for a magnetic resonance imaging angiography (MRA) contrast agent was been signed, making it available to more than 27,000 medical facilities.
June 4, 2010 โ A monthly, online service was launched today that allows clinicians to review and interpret general and cardiac nuclear medicine studies from anywhere in the world for a low monthly rate. The Medx Web Viewer permits interpretation of any original equipment manufacturer (OEM) dataset with nuclear medicine-specific color tables and cine movie displays.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 3, 2010 โ Six-month data from the first 45 patients enrolled in the second stage of a trial for a bioresorbable stent demonstrated strong results. Abbott's bioresorbable vascular scaffold (BVS) showed a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots.
June 3, 2010 โ A joint research agreement will explore the targeted delivery of experimental therapeutics based on ribonucleic acid (RNA) interference (RNAi). Philips Healthcare and RXi Pharmaceuticals Corp. say imaging compounds based on RNAi represent a promising new class of drugs for the targeted treatment of a number of diseases including cancer and cardiovascular disease.
June 3, 2010 โ A single photon emission tomography (SPECT) system may significantly reduce patient and staff radiation exposure by using significantly less radioactive imaging agent.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
June 2, 2010 โ Covidien announced yesterday it is purchasing ev3 Inc. for $2.6 billion to expand its percutaneous vascular portfolio. The company hopes to become a leading endovascular player in both the peripheral vascular and neurovascular markets.
June 2, 2010 โ A portable point-of-care prothrombin time/international normalized ratio (PT/INR) analyzer was released this week. The system detect blood clotting time for patients stabilized on oral anticoagulation medications such as warfarin. The CoaguSense PT/INR monitoring system was recently cleared by the U.S.
June 2, 2010 โ Key research on new diagnostic uses for cardiac ultrasound will be presented at the American Society of Echocardiography (ASE) 21st Annual Scientific Sessions June 12-15, in San Diego. Leading experts in cardiology will present and discuss the latest clinical and research developments in adult and pediatric echocardiography. Among the key presentations are: